China Universal Asset Management »

Nautilus Biotechnology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $69k 24k 2.85
2024-06-30 $34k 15k 2.34
2024-03-31 $71k 24k 2.94
2023-12-31 $43k 15k 2.99
2023-09-30 $10k 3.2k 3.16
2023-06-30 $6.3k 1.6k 3.87
2023-03-31 $4.7k 1.7k 2.77
2022-12-31 $2.3k 1.3k 1.80
2022-09-30 $2.0k 1.2k 1.71

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
BlackRock
Vanguard Group
Comprehensive Financial Management
Bain Capital Life Sciences Investors
Amazon
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Tikvah Management
Clarius
Botty Investors

View all funds holding Nautilus Biotechnology